Healthcare Professional View
Discover a new possible™
To advancing AF treatment through focusing on three main areas: innovating new technology solutions, investing in research and publications to advance clinical understanding and improving education and awareness of AF among clinicians and the general public.
Atrial Fibrillation is fast becoming one of the world’s most significant public health issues – affecting 14 millions of lives across EMEA and placing a critical burden on healthcare systems 1-3
CARTO® THERMOCOOL SMARTTOUCH® Catheter
Deliver a measure of success to your cardiac arrhythmia patients with the CARTO® THERMOCOOL SMARTTOUCH® Catheter. The Catheter’s stability results in more consistent contact force, producing more uniform lesions.
VISITAG SURPOINT™ Module (also known as VISITAG with Ablation Index)
By providing a built-in algorithm and standard workflow, VISITAG SURPOINT™ Module allows EPs to focus on a single value – the Ablation Index – which represents stability, power, contact force, and time. With VISITAG SURPOINT™ Module, EPs can reproduce their own successful ablation strategy in a standard and simple way by eliminating variability and improving accuracy.
CARTO® PENTARAYTM NAV eco Catheter
Experience detailed mapping across all four chambers of the heart with the PENTARAYTM NAV eco Catheter. Enjoy high signal resolution using this navigational diagnostic catheter with five soft, flexible splines for full coverage. When the PENTARAYTM NAV eco Catheter is used with our CARTO® 3 MEM version it allows you to sample multiple points of cardiac mapping data simultaneously for reduced procedure and fluoroscopy time.
CARTOSOUND® Module
The CARTOSOUND® Module with SOUNDSTAR® Catheter is the ideal addition to your ablation workflow delivering an extra measure of certainty in complex procedures.
This 3D ultrasound technology gives you all the benefits of traditional intracardiac echo while enabling full integration of the CARTO® 3 System.
CARTO SMARTTOUCH™ Software Module
Add an additional dimension of certainty with the knowledge that comes from seeing all ablation parameters displayed in real-time on a single screen. CARTO SMARTTOUCH™ Software Module allows active measurement of contact force and catheter tip direction. Integration with the CARTO® 3 System incorporates VISITAG SURPOINT™ Module (also known as VISITAG with Ablation Index) technology to display key ablation variables related to lesion formation.
1. Zoni-Berisso M., L. C. D. (2014). Epidemiology of atrial fibrillation: European perspective.
Clinical Epidemiology 2014:6:213-220.
2. Ball et al. Atrial fibrillation: Profile and burden of an evolving epidemic in the 21st Century. International Journal of Cardiology 167 (2013) 1807–1824.
3. Data extracted by Global Burden Disease (GBD) Results Tool - GHDx website 24/10/2017
This site is published by Johnson & Johnson Medical NV/SA which is solely responsible for its content.
The minimum age for the website is 18. This site is intended for Healthcare Professionals from United Kingdom and Ireland where English is accepted in accordance with local laws and regulations, if applicable.
Important Information: Prior to use, refer to the “instructions for use” supplied with these devices for indications, contraindications, side effects, suggested procedure, warnings and precautions. As part of the Biosense Webster policy of continuous product development we reserve the right to change product specifications without prior notification.
Always verify catheter tip location using fluoroscopy or IC signals and consult the CARTO® 3 System User Guide regarding recommendations for fluoroscopy use.* Catheter advancement should be done under fluoroscopic guidance. Do not use excessive force to advance or withdraw the catheter when resistance is encountered. Careful catheter manipulation must be performed in order to avoid cardiac damage, perforation, or tamponade.
*Sporton S, Earley M, Nathan A, and Schilling R, Electroanatomic versus fluoroscopic mapping for catheter ablation procedures: A prospective randomized study. Journal of Cardiovascular Electrophysiology 2004;15,3:310-315
Product availability may differ in each country. Please contact us to find out further information.
Third party trademarks used herein are trademarks of their respective owners.
For full product details and precautions, please consult the IFU.
This publication is not intended for distribution outside of the UK & Ireland region.
127436-191112 UK
